161 related articles for article (PubMed ID: 33179827)
1. Late intervention in the remnant kidney model attenuates proteinuria but not glomerular filtration rate decline.
Veitch MR; Thai K; Zhang Y; Desjardins JF; Kabir G; Connelly KA; Gilbert RE
Nephrology (Carlton); 2021 Mar; 26(3):270-279. PubMed ID: 33179827
[TBL] [Abstract][Full Text] [Related]
2. Sirtuin 1 Activation Reduces Transforming Growth Factor-β1-Induced Fibrogenesis and Affords Organ Protection in a Model of Progressive, Experimental Kidney and Associated Cardiac Disease.
Zhang Y; Connelly KA; Thai K; Wu X; Kapus A; Kepecs D; Gilbert RE
Am J Pathol; 2017 Jan; 187(1):80-90. PubMed ID: 27993241
[TBL] [Abstract][Full Text] [Related]
3. Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD.
Kepecs DM; Yuen DA; Zhang Y; Thai K; Connelly KA; Gilbert RE
J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27638853
[TBL] [Abstract][Full Text] [Related]
4. Changing Protein Permeability with Nephron Loss: Evidence for a Human Remnant Nephron Effect.
Willows J; Odudu A; Logan I; Sheerin N; Tomson C; Ellam T
Am J Nephrol; 2019; 50(2):152-159. PubMed ID: 31269482
[TBL] [Abstract][Full Text] [Related]
5. 5/6th nephrectomy in combination with high salt diet and nitric oxide synthase inhibition to induce chronic kidney disease in the Lewis rat.
van Koppen A; Verhaar MC; Bongartz LG; Joles JA
J Vis Exp; 2013 Jul; (77):e50398. PubMed ID: 23851420
[TBL] [Abstract][Full Text] [Related]
6. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
7. Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.
Fabris B; Candido R; Armini L; Fischetti F; Calci M; Bardelli M; Fazio M; Campanacci L; Carretta R
J Hypertens; 1999 Dec; 17(12 Pt 2):1925-31. PubMed ID: 10703891
[TBL] [Abstract][Full Text] [Related]
8. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.
Diamond JR; Anderson S
Am J Pathol; 1990 Dec; 137(6):1323-32. PubMed ID: 2260622
[TBL] [Abstract][Full Text] [Related]
9. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
10. Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease.
Zhang Y; Thai K; Kepecs DM; Gilbert RE
PLoS One; 2016; 11(1):e0144640. PubMed ID: 26741142
[TBL] [Abstract][Full Text] [Related]
11. Early, but not late therapy with a vasopressin V1a-antagonist ameliorates the development of renal damage after 5/6 nephrectomy.
Windt WA; Tahara A; Kluppel AC; de Zeeuw D; Henning RH; van Dokkum RP
J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):217-24. PubMed ID: 17347933
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
[TBL] [Abstract][Full Text] [Related]
13. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
14. Effect of enalapril on glomerular filtration rate and proteinuria in children with chronic kidney disease: a randomized controlled trial.
Hari P; Sahu J; Sinha A; Pandey RM; Bal CS; Bagga A
Indian Pediatr; 2013 Oct; 50(10):923-8. PubMed ID: 23585423
[TBL] [Abstract][Full Text] [Related]
15. Blood capillary rarefaction and lymphatic capillary neoangiogenesis are key contributors to renal allograft fibrosis in an ACE inhibition rat model.
Hamar P; Kerjaschki D
Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H981-H990. PubMed ID: 27496878
[TBL] [Abstract][Full Text] [Related]
16. Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.
Noda M; Fukuda R; Matsuo T; Ohta M; Nagano H; Imura Y; Nishikawa K; Shibouta Y
Kidney Int Suppl; 1997 Dec; 63():S136-9. PubMed ID: 9407442
[TBL] [Abstract][Full Text] [Related]
17. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
Kanazawa M; Kawamura T; Li L; Sasaki Y; Matsumoto K; Kataoka H; Ito O; Minami N; Sato T; Ootaka T; Kohzuki M
Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
[TBL] [Abstract][Full Text] [Related]
18. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
[TBL] [Abstract][Full Text] [Related]
19. Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.
Jackson B; Cubela R; Debrevi L; Whitty M; Johnston CI
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S167-9. PubMed ID: 2455124
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
